Peripheral lymphocyte markers as surrogate measures of immunosuppression and post-transplant clinical states
- 1 May 2004
- journal article
- Published by Elsevier in Clinical and Applied Immunology Reviews
- Vol. 4 (4) , 225-238
- https://doi.org/10.1016/j.cair.2004.01.002
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Therapeutic drug monitoring of immunosuppressant drugs in clinical practiceClinical Therapeutics, 2002
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation, 2001
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- Immunophilins: Their Properties and Their Potential Role in Therapeutic Drug MonitoringTherapeutic Drug Monitoring, 2000
- QUANTITATION OF IMMUNOSUPPRESSION BY FLOW CYTOMETRIC MEASUREMENT OF THE CAPACITY OF T CELLS FOR INTERLEUKIN-2 PRODUCTION1Transplantation, 1998
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Detection of intracellular cytokines by flow cytometryJournal of Immunological Methods, 1993
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976